辉瑞季报数据现转折迹象

来源: 于 2025-04-29 09:16:18 [旧帖] [给我悄悄话] 本文已被阅读：次
  • Pfizer reports first YoY revenue growth since Q4 2022, reaching 192M+ patients in H1 2024
  • Company raises full-year revenue and earnings guidance for 2024, signaling optimism
  • Focus on oncology leadership, pipeline innovation, and shareholder value; Seagen integration progressing
  • Cost-realignment and manufacturing optimization expected to save $1.5B+ by 2027
  • Confident in navigating IRA impact; core business strong with key products showing notable performance

Pfizer reported a YoY revenue growth not seen since the final quarter of 2022